Tag Archives: FDA

Fixed-Dose Combination of Memantine Extended Release and Donepezil for Alzheimer’s Disease: Licensing Application Submitted to FDA (Biospace Inc.)

Summary A new drug application has been submitted to the FDA (in the United States) for a fixed-dose combination of memantine extended release and donepezil for the treatment of moderate to severe Alzheimer’s Disease dementia. “Using the two drugs together … Continue reading

Posted in For Doctors (mostly), For Nurses and Therapists (mostly), For Researchers (mostly), International, Management of Condition, Pharmacological Treatments, Quick Insights | Tagged , , , , , , , , , , , , , , , , , , , , , | Leave a comment

Quick Insight: United States Perspective on Dementia Research Funding and Progress (Cure Alzheimer’s Fund)

Summary This video gives an overview of the organisations and funding arrangements behind recent collaborative research work on Alzheimer’s Disease, and other form of dementia, in the USA. “Cure Alzheimer’s Fund and the National Institute of Mental Health (NIMH) are … Continue reading

Posted in Charitable Bodies, For Researchers (mostly), International, Non-Pharmacological Treatments, Pharmacological Treatments, Proposed for Next Newsletter, Quick Insights, Universal Interest | Tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , | Leave a comment